Who owns Takeda Pharmaceutical (TAK)? Superinvestor holders
2 superinvestors of the 157 tracked here hold Takeda Pharmaceutical (TAK) in their latest 13F filing, with $77.9M between them. Charles Brandes (founder) gives it the most weight: 0.53% of the reported portfolio. In their latest reported quarter, Richard Pzena added; Charles Brandes (founder) reduced.
Key facts
- Superinvestors holding it
- 2 of 157
- Biggest holder
- Charles Brandes (founder), $77.1M
- Largest weight
- Charles Brandes (founder), 0.53%of their portfolio
- Combined value
- $77.9M
- Bought last quarter
- 1
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Charles Brandes (founder)Brandes Investment Partners | 0.53% | $77.1M | 4.24M | ▼ Reduced 6.6% | −300.5K | Q3 2026 |
| 2 | Richard PzenaPzena Investment Management | 0.00% | $824.2K | 45.31K | ▲ Added 20% | +7.49K | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 2 | 4.28M | $77.9M | 1 | 1 |
| Q2 2026 | 157 | 2 | 4.58M | $73.4M | 2 | 0 |
| Q1 2026 | 157 | 2 | 4.46M | $82.6M | 2 | 0 |
| Q4 2025 | 157 | 2 | 3.9M | $60.8M | 1 | 2 |
| Q3 2025 | 157 | 1 | 3.93M | $57.6M | 1 | 0 |
| Q2 2025 | 157 | 1 | 3.71M | $57.4M | 1 | 0 |
| Q1 2025 | 156 | 1 | 3.5M | $52.1M | 1 | 1 |
| Q4 2024 | 156 | 2 | 3.56M | $47.2M | 0 | 2 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Charles Brandes (founder) | 4.24M | 4.54M | 4.43M | 3.88M | 3.93M | 3.71M | 3.5M | 3.04M |
| Richard Pzena | 45.31K | 37.82K | 28.36K | 20.63K | — | — | — | — |
| Sarah Ketterer | — | — | — | — | — | — | — | 522.03K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own TAK?
In their latest 13F filings: Charles Brandes (founder) (0.53% of the portfolio, $77.1M), Richard Pzena (0.00% of the portfolio, $824.2K).
Who bought TAK last quarter?
Richard Pzena (added 20%). “Last quarter” is each investor's latest reported quarter.
Who sold TAK last quarter?
Reduced: Charles Brandes (founder) (6.6% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Takeda Pharmaceutical (TAK)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/TAK/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to TAK by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.